LTRN - Lantern Pharma GAAP EPS of -$0.44 misses by $0.01
2023-08-09 17:15:39 ET
- Lantern Pharma press release ( NASDAQ: LTRN ): Q2 GAAP EPS of -$0.44 misses by $0.01 .
- Cash, cash equivalents, and marketable securities were approximately $48.0 million as of June 30.
- Shares +0.64% AH.
For further details see:
Lantern Pharma GAAP EPS of -$0.44 misses by $0.01